Onderneming MEDADVISO Australian S.E.
Aandelen
Geavanceerde medische apparatuur & technologie
Vakgebied
Verkoop per activiteit
AUD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
79,7
%
| 54 | 79,2 % | 78 | 79,7 % | +45,54% |
MedAdvisor
20,3
%
| 14 | 20,7 % | 20 | 20,3 % | +41,90% |
United Kingdom
0,1
%
| 0 | 0,1 % | 0 | 0,1 % | +0,05% |
Verkoop per regio
AUD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
79,7
%
| 54 | 79,2 % | 78 | 79,7 % | +45,54% |
Australia
20,3
%
| 14 | 20,7 % | 20 | 20,3 % | +41,90% |
United Kingdom
0,1
%
| 0 | 0,1 % | 0 | 0,1 % | +0,05% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Ratliff
CEO | Chief Executive Officer | - | 15-07-22 |
Ancila Desai
DFI | Director of Finance/CFO | - | 17-10-22 |
Craig Schnuriger
CTO | Chief Tech/Sci/R&D Officer | - | 30-06-20 |
Wayne Marinoff
PRN | Corporate Officer/Principal | - | - |
Corporate Secretary | - | 30-03-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Linda Jenkinson
CHM | Chairman | - | 28-02-22 |
Kevin Hutchinson
BRD | Director/Board Member | - | 23-11-22 |
Richard Ratliff
CEO | Chief Executive Officer | - | 15-07-22 |
Lucas Merrow
BRD | Director/Board Member | - | 10-08-21 |
Jim Xenos
BRD | Director/Board Member | - | 12-11-15 |
Sandra Hook
BRD | Director/Board Member | - | 19-01-16 |
Catherine Hill
BRD | Director/Board Member | 65 | 24-05-23 |
Anthony Tassone
BRD | Director/Board Member | - | 27-07-22 |
Brett Magun
BRD | Director/Board Member | - | 24-05-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 546 929 824 | 332 342 724 ( 60,77 %) | 0 | 60,77 % |
Bedrijfsgegevens
![Adres MEDADVISO](https://cdn.zonebourse.com/static/address/25209991.png)
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,38% | 29,93 mld. | |
+49,49% | 9,7 mld. | |
+34,36% | 4,42 mld. | |
-42,64% | 2,3 mld. | |
-10,39% | 1,52 mld. | |
-28,81% | 1,21 mld. | |
-42,92% | 967 mln. | |
+8,92% | 957 mln. | |
-47,18% | 746 mln. |